The development of the cytokinesis-block (CB) technique has made the human lymphocyte micronucleus assay (MN) a reliable and precise method for assessing chromosome damage. Recent studies in our laboratory have confirmed that this method is a sensitive indicator of in vivo radiation exposure in patients undergoing fractionated partial-body radiotherapy and rodents exposed to uniform whole-body irradiation, thus supporting the application of the cytokinesis-block micronucleus (CBMN) assay for biological dosimetry. To further define the use of this assay in biomonitoring, we have also undertaken extensive studies to determine the spontaneous level of MN in normal human populations and its relationship to various lifestyle factors. During the past year, we have also developed a new variation to the CBMN assay that enables the conversion of excision-repairable lesions to MN within one cell-cycle using cytosine arabinoside. With this method the slope of the in vitro dose-response curves was increased by a factor of 1.8 for X-rays, 10.3 for ultraviolet (254 nm) radiation, and approximately 40-fold for methylnitrosourea. Consequently, the CBMN assay can now be used not only to measure whole chromosome loss or chromosome breaks but also excision repair events. The versatility and simplicity of the CBMN assay together with new developments in automation should enable its successful application in monitoring exposed populations as well as identifying mutagen-sensitive individuals within a population.
Introduction
The level of genetic integrity of human populations is increasingly under threat due to industrial activities that result in exposure to chemical and physical genotoxins. Other factors that can influence genetic damage include lifestyle factors (e.g., diet), various medical therapies, and climatic changes (e.g., increased exposure to ultravoilet radiation due to depletion of atmospheric ozone). It is therefore important to be able to a) determine what is an acceptable level of genetic damage in a human population, b) identify individuals who could be hypersensitive to selected genotoxins, c) effectively screen new chemicals that are released into the environment, d) determine the level of increase in genetic damage in a population following a major accident, and e) routinely monitor individuals who are occupationally exposed to agents that can be detrimental at the genetic level.
A number of methodologies have been developed over the past 20 years, varying from cytogenetic techniques that can give a broad assessment of mutagenic events to adduct assays that are designed to detect exposure to specific agents. No one technique can satisfy all the requirements identified above, and it is now realized that a variety of methods can be combined to provide an effective screening system (1, 2) .
As part of our effort in this area of research, we have been actively involved in the development of micronucleus (MN) assays in human lymphocytes to measure both whole chromosome loss and chromosome breaks (Fig. 1) . The MN methodology is simple and allows rapid assessment of cells, thus making it an economical procedure to * *^n 0 * FIGURE 1. Micronucleus in a dividing nucleated cell. Micronuclei originate from either lagging chromosomes or chromosome fragments at anaphase. Micronuclei are readily identified because they are morphologically identical to but smaller than the main nuclei. A nondividing cell is unable to express its chromosome damage as micronuclei. Cells that have completed one nuclear division can be accumulated and identified as binucleate cells by adding cytochalsin-B, a cytokinesis blocking agent (3, 4 (3, 4) . As a consequence, the CBMN assay has been shown to be more accurate and more sensitive than the conventional methods that do not distinguish between dividing and nondividing cells (4, 5) . The development of the CBMN assay has enabled direct and valid comparisons with chromosome aberration assays. It has now been shown conclusively that the CBMN assay can detect between 60 and 90% of acentric fragments (6, 7) , although the relative efficiency specific for chromatid deletions as opposed to chromosome deletions has yet to be defined. Furthermore, the CBMN assay combined with kinetochore or centromere detection has been shown to be an optimal procedure for measuring whole chromosome loss events (8) (9) (10) . Further technical developments (e.g., chromosome painting) may also allow the measurement of unequal distribution of chromosomes within daughter nuclei in cytokinesis-blocked binucleate cells. The scope for using the CBMN method in human population monitoring and recent advances in methodology are discussed below.
Spontaneous Micronucleus Frequencies in Human Populations
Spontaneous or baseline MN frequencies in cultured human lymphocytes provide an index of accumulated genetic damage occurring during the lifespan of circulating lymphocytes. The half-life and mean lifespan of longlived T-lymphocytes has been estimated to be 3 years and 4 years, respectively (11, 51) . The observed genetic instability may also reflect accumulated mutations in the stem cell lineage from which the mature lymphocytes originate.
The type of mutations that could contribute to spontaneous micronuclei include a) mutations to kinetochore proteins, centromeres, and spindle apparatus that could lead to unequal chromosome distribution or whole chromosome loss at anaphase, and b) unrepaired DNA strand breaks induced endogenously or as a result of environmental mutagens, which may result in acentric chromosome fragments. Studies using kinetochore antibodies to identify whole chromosomes suggest that approximately 50% of spontaneously occurring micronuclei are the consequence ofwhole chromosome loss and the rest are presumably derived from acentric chromosome fragments (8) (9) (10) .
For the purpose of biological dosimetry, the spontaneous MN frequency refers to the incidence of MN observed in the absence of the environmental risk or exposure that is being assessed. continuous monitoring program of individuals who are occupationally at risk of exposure to a powerful environmental mutagen such as radiation. In this case, individuals act as their own controls, and their MN frequencies are measured before and at regular intervals during their occupation. This situation is ideal because differences in lifestyle factors should not be a confounding factor. However, this approach is also dependent on the reproducibility of the assay; in other words, the assay should provide the same result when measurements are done on the same individual on separate occasions between which no significant exposure to mutagenic agents has occurred. Our own studies on baseline MN Buckton et al. (18) for unstable aberrations in irradiated ankylosing spondylitis patients, thus supporting the theory that MN induced in vivo by ionizing radiation are mainly derived from acentric chromosome fragments.
Since our initial study, it has been shown that the CBMN assay can readily detect the in vivo clastogenic effects of combined radiation (accumulated doses of 10 cGy) and contrast media in patients undergoing excretory urography (19) . Wells et al. (20) confirmed that the CBMN assay can, indeed, readily detect exposures in patients undergoing fractionated partial-body radiotherapy, with the MN index being directly related to the integral dose. As a result of the possible application of the CBMN assay in biological dosimetry after radiation accidents, several laboratories around the world have now established the dose-response parameters after exposure to various sources of ionizing radiation (3, 4, 6, 7, (20) (21) (22) (23) (24) (25) 29) . Furthermore, the Sobel's parallelogram concept of risk estimation (26) is also being implemented to determine the kinetics and extent of MN expression using the mouse as a model (27, 28) .
Our own data have shown that during the 14 days after whole-body irradiation, the MN frequency in spleen lymphocytes declined gradually to approximately half of the value observed immediately after irradiation. By contrast, the MN frequency in peripheral blood lymphocytes increased during the week after irradiation, but ultimately MN frequencies in the blood and spleen became approximately the same by day 14 and did not differ significantly from the MN frequency observed in blood lymphocytes immediately after exposure (27) . Such data suggest that reliable dose estimates with the CBMN assay can still be obtained up to 2 weeks after whole body irradiation.
It has been suggested that the application of the CBMN assay in biological dosimetry after radiation accidents may be compromised by the relatively high background frequency (29, 30) . However, this criticism is diminished by the fact that a) it is comparatively easy to determine a database for baseline MN 
Chemicals
The CBMN assay is increasingly being applied in population studies when significant in vivo exposures to genotoxic chemicals are suspected. Some of these studies have been particularly useful, as they have allowed direct comparison of the CBMN assay with other cytogenetic end points. These investigations included occupational exposure to styrene (31, 32) , chemicals in tannery industries (33) , cyclophosphamide (34) , and intervention trials with paracetamol (35) . In three of these studies (32, 33, 35) , increases in chromatid-type aberrations were reported; however, there was no corresponding increase in the MN index.
On the other hand, a recent report by Osanto et al. (36) has clearly shown that the CBMN assay can detect chromosome damage in the peripheral blood lymphocytes up to 9 years after chemotherapy of patients with testicular carcinoma. The overall impression that is gained from these studies is that the CBMN assay may be relatively insensitive to exposures to chemicals or agents that are either S-phase dependent or mainly induce covalent adducts on DNA.
Relative Insensitivity of the CBMN Assay to Agents That Induce Covalent DNA Adducts but Not Strand Breakage
The cytogenetic lesions that are commonly increased in cells that have divided once after in vivo exposure to S-phase-dependent chemicals are chromatid-type aberrations such as chromatid deletions, achromatic lesions or gaps, and sister chromatid exchanges (11, 37) . The molecular mechanisms responsible for these lesions are not clearly understood; however, it is generally considered that a deletion is the consequence of a double-strand break event, whereas an achromatic lesion or gap may represent a base damage site or a single-strand break that does not result in a complete discontinuity in chromosome structure. As a consequence, of the various chemically induced cytogenetic aberrations, only chromatid or chromosome deletions can convert to lagging chromosome fragments at anaphase and be expressed as a micronucleus. The possible mechanisms underlying chemically induced DNA damage and the repair of covalent adducts suggest that there may be opportunities to improve the conversion of chemically induced base damage to micronuclei. An appropriate method would enable the conversion of adduct sites to single strand breaks in the Go or G1 phase of the first division cycle. Single-strand breaks should convert to double strand breaks after the first S-phase and, consequently, to chromatid breaks and micronuclei by the time the first nuclear division is completed. During the past year, we have concentrated our efforts on developing an appropriate procedure for this approach.
Conversion of Excision-Repairable DNA Lesions to Micronuclei Within One Cell Cycle
The opportunity for enhancing the sensitivity of the CBMN assay to genotoxins that mainly induce chemical adducts on DNA has arisen from studies over the last decade that have shown that cytosine arabinoside (ARA) can greatly enhance induction of chromosome aberrations in human lymphocytes after chemical exposure in vitro (38) (39) (40) . ARA exerts its effect by inhibiting the DNA polymerization step (gap filling) that normally occurs after excision of damaged bases during nucleotide excision repair (long-patch repair) or base-excision repair (shortpatch repair) (41, 42) . As a consequence, excision repair sites are converted to single-strand breaks. Preston and Gooch (39) suggested that it is probable that the interaction of these breaks, or their conversion to double-strand breaks after replicative DNA synthesis, could be the mechanism whereby synergistic increments in chromosome aberrations are produced by ARA after exposure to methylating agents, 4-nitroquinoline-1-oxide, or ionizing radiation. In principle this approach should also enable the conversion of excision repair sites to MN within one cell cycle because acentric chromosome and chromatid fragments are readily converted to MN due to lagging at anaphase (Fig. 3) .
The aim of our approach was therefore to combine the ARA methodology with the CBMN assay (43) . The effect of ARA on MN induction was determined for human lymphocytes exposed in vitro to ionizing radiation and two agents that predominantly produced excision-repairable lesions but were weak inducers of MN in the standard CBMN assay, namely, methylnitrosourea (MNU) and ultravoilet light (T, 254 nm). In the protocols used, the cells were incubated with ARA for most of the G1 phase after exposure to the genotoxin to ensure that a) the maximum number of excision sites were converted to single-strand breaks, and b) to minimize the possibility of gap-filling after removal of ARA before S-phase started ( Table 1 
Conclusion
Since the initial description of the CBMN assay, there have been several reports that have enabled a better definition of its potential for biological dosimetry. The general consensus seems that the CBMN assay, due to its relative ease of implementation and its ability to complement other cytogenetic assays, has an important role to play in biomonitoring genotoxic exposure. However, there also appears to be some concern that the baseline MN frequency in human populations requires better definition if this technique is to effectively discriminate between DNA damage occurring as a result of normal metabolic processes and genotoxic effects due to man-made or natural environmental agents. Our most recent investigations indicate that it is possible to markedly increase the sensitivity of the CBMN assay to genotoxins that mainly induce excision-repairable lesions (43) , and Norman et al. (44) have recently demonstrated that the cytokinesisblock methodology can also be implemented to readily quantify HPRT variants, thus enhancing the role of this technique in mutagenesis research. Finally, one can look forward to further development of automation by image analysis (45) , which should enhance the application of the micronucleus assay in routine screening programs such as assessment of interindividual variation in radiosensitivity (46) , prediction of radiocurability of tumors (47) (48) (49) (50) , and generally in those studies of a molecular epidemiological design (2) that would require several hundred blood samples to be cultured for micronucleus measurement.
